Klaus-Dieter Albrecht has been appointed Managing Director of Synexus Germany. He has taken responsibility for the management of the eight Synexus clinical trial centres in the country including new business and profitability.
Synexus, which is headquartered in Manchester, UK, is a multinational organisation dedicated to the recruitment of patients and running of clinical trials at its own dedicated research centres.
Albrecht has had extensive experience in the CRO marketplace with senior positions at Encorium and Pierrel, as well as working with Schwarz pharma as head of contract management.
Germany is an important market for Synexus and has more clinics than any other country in the firm’s network of 25 clinical trial centres across Europe and Africa.
